EndoGastric funds US sales with $30m round:
This article was originally published in Clinica
Executive Summary
Natural orifice surgery (NOS) specialist EndoGastric Solutions has completed a $30m series D round of financing. Redmond, Washington-based EndoGastric plans to use the new finances to expand sales and marketing efforts for its transoral StomaphyX device for binding tissue in the gastrointestinal tract to help weight loss, and fund the launch of its EsophyX device for treating gastroesophageal reflex disease later this year. The round was lead by DeNovo Ventures and included contributions from existing investors Chicago Growth Partners, MPM Capital, Advanced Technology Ventures, Foundation Medical Partners and Oakwood Medical Investors. The financing sees DeNovo's Joe Mandato join the EndoGastric board of directors.